Mesothelioma

Carbone highlighted the growing worldwide problem of asbestos exposure and its link to malignant Dr.

Carbone presented data that show the early detection in patients at high risk for developing malignant Furthermore, he pointed out that ONCONASE's favorable toxicity profile and its well-documented mechanism of action, which directly affects the pathway that has been shown to cause asbestos carcinogenesis, position ONCONASE for potential early administration to populations "at-risk" for If clinically validated, such a new approach might enable physicians to use ONCONASE as a chemopreventive agent to potentially prevent the onset of "The potential of ONCONASE as an early first-line preventative treatment for Carbone.

"With approximately more than 25 million asbestos exposure cases reported worldwide, we believe that ONCONASE might play a greater role in the treatment protocols for a much larger population than was originally envisioned for this dismal disease." Dr.

Carbone i...

Read more...